Creative Planning’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Creative Planning’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,855	Closed	-$20K	–	2487
2022 Q2	$20K	Buy	+16,855	New	+$17.6K	﹤0.01%	2146
2017 Q3	–	Sell	-2,000	Closed	-$3K	–	4029
2017 Q2	$3K	Hold	2,000	–	–	﹤0.01%	4227
2017 Q1	$4K	Hold	2,000	–	–	﹤0.01%	4095
2016 Q4	$4K	Hold	2,000	–	–	﹤0.01%	4090
2016 Q3	$3K	Buy	2,000 +1,500	+300%	+$1.82K	﹤0.01%	4154
2016 Q2	$0	Hold	500	–	–	﹤0.01%	4580
2016 Q1	$0	Hold	500	–	–	﹤0.01%	4609
2015 Q4	$1K	Hold	500	–	–	﹤0.01%	4282
2015 Q3	$1K	Buy	+500	New	+$974	﹤0.01%	4186
2015 Q2	–	Sell	-500	Closed	-$2K	–	3319
2015 Q1	$2K	Hold	500	–	–	﹤0.01%	3935
2014 Q4	$2K	Hold	500	–	–	﹤0.01%	3874
2014 Q3	$1K	Buy	+500	New	+$3.34K	﹤0.01%	3893

Creative Planning's MBII Position: Q3 2022 in Review

Creative Planning sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 16,855 shares — an estimated $20K sold.

Creative Planning first reported a position in MBII in Q3 2014 and held it in 12 quarters. The position peaked at $20K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Creative Planning reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Creative Planning sold 16,855 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $20K.
Creative Planning first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 12 quarters.
Creative Planning's Marrone Bio Innovations, Inc. position peaked at $20K in Q2 2022.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.